<DOC>
	<DOCNO>NCT02511912</DOCNO>
	<brief_summary>This prospective , non-randomized , open label , single-arm multi-center study .</brief_summary>
	<brief_title>REducing Lung Congestion Symptoms Using thE V-wavE Shunt Advanced Heart Failure</brief_title>
	<detailed_description>This prospective , non-randomized , open label , single-arm multi-center study evaluate perfromance safety V-Wave interatrial shunt implant chronic heart failure patient reduce preserved ejection fraction .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<criteria>1 . Chronic ( &gt; 6 month ) ischemic nonischemic cardiomyopathy , ACC/AHA Stage C , NYHA Class III ambulatory Class IV heart failure , Receiving optimal guideline direct medical therapy define ACC/AHA guideline 2 . Patient legally acceptable representative , sign write informed consent form ( ICF ) participate study 3 . Ejection Fraction â‰¥ 15 % 1 . Right Heart Failure 2 . Right Atrial Pressure ( RAP ) &gt; Left Atrial Pressure ( LAP ) 3 . Congenital heart disease 4 . Severe pulmonary hypertension 5 . Severe restrictive obstructive lung disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>July 2015</verification_date>
</DOC>